Involvement of spinal glutamate in nociceptive behavior induced by intrathecal administration of hemokinin-1 in mice
Involvement of spinal glutamate in nociceptive behavior induced by intrathecal administration of hemokinin-1 in mice
复制标题
DOI:
10.1016/j.neulet.2016.02.027
复制
发表时间:
2016-03
影响因子:
2.5
通讯作者:
C. Watanabe;H. Mizoguchi;G. Bagetta;S. Sakurada
中科院分区:
文献类型:
--
作者:
C. Watanabe;H. Mizoguchi;G. Bagetta;S. Sakurada
The most recently identified tachykinin, hemokinin-1, was cloned from mouse bone marrow. While several studies indicated that hemokinin-1 is involved in pain and inflammation, the physiological functions of hemokinin-1 are not fully understood. Our previous research demonstrated that the intrathecal (i.t.) administration of hemokinin-1 (0.00625–1.6 nmol) dose-dependently induced nociceptive behaviors, consisting of scratching, biting and licking in mice, which are very similar with the nociceptive behaviors induced by the i.t. administration of substance P. Low-dose (0.0125 nmol) hemokinin-1-induced nociceptive behavior was inhibited by a specific NK1receptor antagonist; however, high-dose (0.1 nmol) hemokinin-1-induced nociceptive behavior was not affected.In the present study, we found that the nociceptive behaviors induced by hemokinin-1 (0.1 nmol) were inhibited by the i.t. co-administration of MK-801 or D-APV, which are NMDA receptor antagonists. Moreover, we measured glutamate in the extracellular fluid of the mouse spinal cord using microdialysis. The i.t. administration of hemokinin-1 produced a significant increase in glutamate in the spinal cord, which was significantly reduced by co-administration with NMDA receptor antagonists. These results suggest that hemokinin-1-induced nociceptive behaviors may be mediated by the NMDA receptor in the spinal cord.